Posted by ABMN Staff on Apr 24th, 2024
Surmodics (NASDAQ:SRDX – Get Free Report) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued on Wednesday.
Separately, Needham & Company...
More of this article »